A carregar...
Adjuvant Therapy Reduces Rate of Dissemination but Shortens Survival Thereafter
In the subgroup of patients who suffer from metastases despite adjuvant therapy, survival after dissemination is shortened. This is partially due to an adjuvant chemotherapy-induced resistance to previous treatment and may be similar after hormonal therapy and immunotherapy.
Na minha lista:
| Publicado no: | Oncologist |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
AlphaMed Press
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4492238/ https://ncbi.nlm.nih.gov/pubmed/26069279 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2015-0116 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|